Maybe someone has already posted some of the below - if so, apologies.
The following excerpts of research report on Magnis - by Evolution Capital. 25/10/22
Share price at the time was $0.37.50 cents
On Track to Deliver Innovative Commercial LIB Solutions.
Technology: from a prospective graphite miner, Magnis has evolved into a technology company about to deliver innovative commercial Lithium-Ion battery (LIB) solutions to the electric vehicle and energy storage industries.
Investments and Partnerships: MNS has now strategic assets, investments and technology partnerships in vital components of the global Lithium-Ion Battery value-chain. Magnis’ technology partner, Charge CCCV (C4V) is a cutting-edge LIB technology company based in Binghamton, New York with expertise and patented discoveries in LIB composition and manufacture. MNS holds a 9.65% stake in C4V and have also licensed advanced graphite processing technology from C4V.
iM3NY: iM3NY (62% MNS, 33% C4V) is building a Gigafactory in Endicott, NY state, ramping up nameplate capacity from 1.8 GWh in 2023 to 38 GWh in 2030. We estimate that about 50% of the revenues for FY2023 have been secured by the sales’ contracts announced. Many more are at various stages of negotiation.
Competitive Advantages: cells and packs are based on an improved lithium- iron-phosphate (LFP) chemistry free of expensive and price volatile nickel and cobalt, providing more than 20% energy density than traditional LFP cells with lower cost than nickel-manganese-cobalt (NMC) cells. The cells have been commercially tested and shown to vastly extend battery life, provide greater safety, lower cost and improve charge performance addressing each of the issues of current LIBs. Manufacturing will also benefit from low-cost renewable energy below 5¢/kWh from nearby Niagara Falls hydropower station.
News Flow and Share Price Catalyst: the key driver adding shareholder value is securing further sale contracts to match as much as possible the expected ramp-up of the iM3NY Gigafactory capacity and production.
MNS valuation: Considering the above parameters, an equity capital raising of A$30m at $0.40 (75m shares) in FY2023, and subject to securing further sale contracts, our Base Case valuation stands at A$1,339m or A$1.15 per share.
MNS Price at posting:
42.0¢ Sentiment: Hold Disclosure: Held
(20min delay)